Cargando…

Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study

INTRODUCTION: Systemic inflammation with elevated oxidative stress causing neuroinflammation is considered a major factor in the pathogenesis of Parkinson's disease (PD). The interface between systemic circulation and the brain parenchyma is the blood-brain barrier (BBB), which also plays a rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chiun-Chieh, Chen, Hsiu-Ling, Chen, Meng-Hsiang, Lu, Cheng-Hsien, Tsai, Nai-Wen, Huang, Chih-Cheng, Chang, Yung-Yee, Li, Shau-Hsuan, Chen, Yueh-Sheng, Chiang, Pi-Ling, Lin, Wei-Che
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376437/
https://www.ncbi.nlm.nih.gov/pubmed/32733633
http://dx.doi.org/10.1155/2020/2591248
_version_ 1783562045191356416
author Yu, Chiun-Chieh
Chen, Hsiu-Ling
Chen, Meng-Hsiang
Lu, Cheng-Hsien
Tsai, Nai-Wen
Huang, Chih-Cheng
Chang, Yung-Yee
Li, Shau-Hsuan
Chen, Yueh-Sheng
Chiang, Pi-Ling
Lin, Wei-Che
author_facet Yu, Chiun-Chieh
Chen, Hsiu-Ling
Chen, Meng-Hsiang
Lu, Cheng-Hsien
Tsai, Nai-Wen
Huang, Chih-Cheng
Chang, Yung-Yee
Li, Shau-Hsuan
Chen, Yueh-Sheng
Chiang, Pi-Ling
Lin, Wei-Che
author_sort Yu, Chiun-Chieh
collection PubMed
description INTRODUCTION: Systemic inflammation with elevated oxidative stress causing neuroinflammation is considered a major factor in the pathogenesis of Parkinson's disease (PD). The interface between systemic circulation and the brain parenchyma is the blood-brain barrier (BBB), which also plays a role in maintaining neurovascular homeostasis. Vascular cell adhesion molecule-1 (VCAM-1) and microRNAs (miRNAs) regulate brain vessel endothelial function, neoangiogenesis, and, in turn, neuronal homeostasis regulation, such that their dysregulation can result in neurodegeneration, such as gray matter atrophy, in PD. OBJECTIVE: Our aim was to evaluate the associations among specific levels of gray matter atrophy, peripheral vascular adhesion molecules, miRNAs, and clinical disease severity in order to achieve a clearer understanding of PD pathogenesis. METHODS: Blood samples were collected from 33 patients with PD and 27 healthy volunteers, and the levels of VCAM-1 and several miRNAs in those samples were measured. Voxel-based morphometry (VBM) analysis was performed using 3 T magnetic resonance imaging (MRI) and SPM (Statistical Parametric Mapping software program). The associations among the vascular parameter, miRNAs, gray matter volume, and clinical disease severity measurements were evaluated by partial correlation analysis. RESULTS: The levels of VCAM-1, miRNA-22, and miRNA-29a expression were significantly elevated in the PD patients. The gray matter volume atrophy in the left parahippocampus, bilateral posterior cingulate gyrus, fusiform gyrus, left temporal gyrus, and cerebellum was significantly correlated with increased clinical disease severity, the upregulation of miRNA levels, and increased vascular inflammation. CONCLUSION: Patients with PD seem to have abnormal levels of vascular inflammatory markers and miRNAs in the peripheral circulation, and these levels are correlated with specific brain volume changes. This study reinforces the associations among peripheral inflammation, the BBB interface, and gray matter atrophy in PD and further demonstrates that BBB dysfunction with neurovascular impairment may play an important role in PD progression.
format Online
Article
Text
id pubmed-7376437
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-73764372020-07-29 Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study Yu, Chiun-Chieh Chen, Hsiu-Ling Chen, Meng-Hsiang Lu, Cheng-Hsien Tsai, Nai-Wen Huang, Chih-Cheng Chang, Yung-Yee Li, Shau-Hsuan Chen, Yueh-Sheng Chiang, Pi-Ling Lin, Wei-Che Oxid Med Cell Longev Research Article INTRODUCTION: Systemic inflammation with elevated oxidative stress causing neuroinflammation is considered a major factor in the pathogenesis of Parkinson's disease (PD). The interface between systemic circulation and the brain parenchyma is the blood-brain barrier (BBB), which also plays a role in maintaining neurovascular homeostasis. Vascular cell adhesion molecule-1 (VCAM-1) and microRNAs (miRNAs) regulate brain vessel endothelial function, neoangiogenesis, and, in turn, neuronal homeostasis regulation, such that their dysregulation can result in neurodegeneration, such as gray matter atrophy, in PD. OBJECTIVE: Our aim was to evaluate the associations among specific levels of gray matter atrophy, peripheral vascular adhesion molecules, miRNAs, and clinical disease severity in order to achieve a clearer understanding of PD pathogenesis. METHODS: Blood samples were collected from 33 patients with PD and 27 healthy volunteers, and the levels of VCAM-1 and several miRNAs in those samples were measured. Voxel-based morphometry (VBM) analysis was performed using 3 T magnetic resonance imaging (MRI) and SPM (Statistical Parametric Mapping software program). The associations among the vascular parameter, miRNAs, gray matter volume, and clinical disease severity measurements were evaluated by partial correlation analysis. RESULTS: The levels of VCAM-1, miRNA-22, and miRNA-29a expression were significantly elevated in the PD patients. The gray matter volume atrophy in the left parahippocampus, bilateral posterior cingulate gyrus, fusiform gyrus, left temporal gyrus, and cerebellum was significantly correlated with increased clinical disease severity, the upregulation of miRNA levels, and increased vascular inflammation. CONCLUSION: Patients with PD seem to have abnormal levels of vascular inflammatory markers and miRNAs in the peripheral circulation, and these levels are correlated with specific brain volume changes. This study reinforces the associations among peripheral inflammation, the BBB interface, and gray matter atrophy in PD and further demonstrates that BBB dysfunction with neurovascular impairment may play an important role in PD progression. Hindawi 2020-07-14 /pmc/articles/PMC7376437/ /pubmed/32733633 http://dx.doi.org/10.1155/2020/2591248 Text en Copyright © 2020 Chiun-Chieh Yu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yu, Chiun-Chieh
Chen, Hsiu-Ling
Chen, Meng-Hsiang
Lu, Cheng-Hsien
Tsai, Nai-Wen
Huang, Chih-Cheng
Chang, Yung-Yee
Li, Shau-Hsuan
Chen, Yueh-Sheng
Chiang, Pi-Ling
Lin, Wei-Che
Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study
title Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study
title_full Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study
title_fullStr Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study
title_full_unstemmed Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study
title_short Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study
title_sort vascular inflammation is a risk factor associated with brain atrophy and disease severity in parkinson's disease: a case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376437/
https://www.ncbi.nlm.nih.gov/pubmed/32733633
http://dx.doi.org/10.1155/2020/2591248
work_keys_str_mv AT yuchiunchieh vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT chenhsiuling vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT chenmenghsiang vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT luchenghsien vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT tsainaiwen vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT huangchihcheng vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT changyungyee vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT lishauhsuan vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT chenyuehsheng vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT chiangpiling vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy
AT linweiche vascularinflammationisariskfactorassociatedwithbrainatrophyanddiseaseseverityinparkinsonsdiseaseacasecontrolstudy